The University of Minnesota Medical School secured a $3.3 million NIH grant to conduct a comprehensive, five-year longitudinal study focused on infants born with congenital cytomegalovirus (cCMV) infection. The research aims to deepen understanding of cCMV's impacts on child development and identify biomarkers for early intervention. This significant funding underlines commitment to combating a leading cause of neurodevelopmental disabilities and hearing loss worldwide.